Phase II trial of elinogrel in patients with stable coronary artery disease and high platelet reactivity who did not respond to clopidogrel.
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2008
At a glance
- Drugs Aspirin; Clopidogrel; Elinogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Sponsors Portola Pharmaceuticals
- 11 Nov 2008 Results presented at the American Heart Association's Annual Scientific Sessions 2008.
- 11 Nov 2008 New trial record.